Obtaining pharmacoeconomic data in health care organizations.
The article illustrates the process and techniques of obtaining or collecting pharmacoeconomic data in various health care organizations, focusing on hospitals, physicians' offices, and pharmacies as the research settings. The role that pharmacoeconomic data have in the decision-making process as well as the perspective of the decision maker are also discussed. The three primary components needed to conduct a complete pharmacoeconomic analysis (clinical outcomes, humanistic outcomes, and economic outcomes) are described in relation to the health care organization. The strengths, weaknesses, advantages, and disadvantages of such data are discussed. Various databases that are accessible within each organization are also outlined.
College of Pharmacy, University of South Carolina, Columbia.
C M
CM
Kozma
L J
LJ
Kirchdoerfer
D003625:Data Collection; D004341:Drug Evaluation / Q000191:economics*; D017850:Economics, Pharmaceutical / Q000706:statistics & numerical data*; D017048:Health Care Costs / Q000706:statistics & numerical data; D006295:Health Resources / Q000706:statistics & numerical data; D006761:Hospitals; D017063:Outcome Assessment, Health Care / Q000191:economics*; D010824:Physicians' Offices; D012109:Research Support as Topic; D014481:United States